The final diagnostic form the evolving hybrid PET/MR tree will take is uncertain, but it has already begun to blossom. Thus, the low-hanging clinical fruit has lured a number of medical centers to early adoption. Experts weigh in on the potential that PET/MR may hold for various neurologic, oncologic and cardiovascular conditions.

This issue highlights the emergence of PET/MR, which follows the introduction of SPECT/CT and PET/CT that have convincingly shown that multimodality imaging can result in significantly improved disease characterization.

Molecular breast imaging is proving its worth as an low-dose alternative to MRI for women with dense breasts.

While 18F-FDG PET is the gold standard for evaluating and managing patients with lung cancer, recent data have shown it also could be beneficial in diagnosing, staging and monitoring of small cell lung cancer.

The global market for medical ultrasound equipment is projected to reach $6.9 billion by 2017, reveals a report by Global Industry Analysts, Inc., San Jose, California.

This article discusses the recent updates in Alzheimers detection using amyloid PET radiotracer 18F-flutemetamol, proteins in the cerebrospinal fluid and blood.

Non-radiologist physicians have contributed to the widespread use of point-of-care (POC) ultrasound, but radiologists remain the primary users, according to a study in the November issue of the Journal of the American College of Radiology.

The rate of death from lung cancer is not lowered by annual chest x-ray screening compared with usual care, reveals a study of published in the online edition of the Journal of the American Medical Association and slated to appear in the November 2 print edition.